At this time, posts about Hanmi Pharm are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 1,257 shares of Hanmi Pharm, and institutions have purchased a net 5,000 shares. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.


As of 1:30 PM on the 2nd, Hanmi Pharm's stock price is 318,000 KRW, down 7.29% from the previous day, with a trading volume of 204,708 shares, which is 303.73% of the 5-day average trading volume.


In addition to Hanmi Pharm, posts by investors are also rapidly increasing regarding Hanmi Science (008930), Green Cross LabCell (144510), and KineMaster (139670).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing